Los Altos, CA, United States of America

Daniel Kirchhofer

This inventor holds 28 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent, primarily in Antibody Therapeutics. Top assignees: Genentech, Inc., Genetech, Inc.. Active years: 2003-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Kirchhofer. Retrieved from https://idiyas.com/inventor/daniel-kirchhofer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 28 

% Patents Active = 39.3

 

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 2003-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-HtrA1 Antibodies
Cardiovascular Disease
NSP4 Inhibitors
Hepatocyte Growth Factor
Anti-PCSK9 Antibodies
Coagulapathic Disorders
Antibody Modulators
Prostasin Modulation
Thrombotic Disorders
Human Anti-Factor IX
Tissue Factor Antibodies
Kunitz Domain Inhibitor
28 patents (USPTO):Explore Patents

Certainly! Here is an article about inventor Daniel Kirchhofer:

Title: Unveiling the Innovative Mind of Daniel Kirchhofer

Introduction:

Daniel Kirchhofer, a visionary inventor based in Los Altos, CA, has made significant contributions to the field of biotechnology with a remarkable portfolio of 28 patents. His groundbreaking work has revolutionized the treatment of various disorders and diseases, showcasing his exceptional talent and dedication to innovation.

Latest Patents:

Among his latest patents are two notable inventions that stand out in the realm of biopharmaceuticals. The first patent involves the development of Anti-HtrA1 antibodies and their methods of use in treating HtrA1-associated disorders, ocular disorders, and complement-associated disorders. The second patent focuses on compositions and methods for treating cardiovascular disease by providing PCSK9 inhibitors and strategies for utilizing them effectively.

Career Highlights:

Daniel Kirchhofer has left an indelible mark on the industry through his tenure at renowned companies like Genentech, Inc. (Corrected from "Genetech, Inc."). His expertise and innovation have paved the way for novel treatments and therapeutic interventions, redefining the standard of care in the biopharmaceutical sector.

Collaborations:

Throughout his career, Daniel Kirchhofer has collaborated with exceptional professionals in the field, including esteemed coworkers such as Yan Wu and Michael Terry Lipari. Together, they have synergized their talents to drive innovation, foster creativity, and push the boundaries of scientific discovery.

Conclusion:

In conclusion, Daniel Kirchhofer's relentless pursuit of innovation and his unwavering commitment to advancing biotechnology have solidified his reputation as a trailblazing inventor. His patents and contributions not only reflect his technical prowess but also underscore his profound impact on improving healthcare and addressing critical medical needs. Daniel Kirchhofer's legacy serves as an inspiration for future generations of inventors, propelling the industry towards new horizons of possibility and progress.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…